TREO Abdominal Stent-Graft System 28-B2-36-080URecalls & reported problems
Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant
All models of TREO Abdominal Stent-Graft System (73)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00843576152397), received between May 2, 2025 and Dec 12, 2025 — classified as 2 injuries.
The most frequently reported specific device problem is “Device Endoleak” (2 reports).
1 other recall cover devices cleared under the same FDA submission (P190015); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Endoleak2
Patient problems
- Clinical Endoleak2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryDec 12, 2025Device Endoleak; Device Endoleak
"PATIENT RETURNED FOR FOLLOW UP VISIT ROUGHLY 6 WKS POST OP. PRESENTED WITH ENDOLEAK IN THE LIMBS OF MAIN BODY. DO NOT KNOW YET HOW PHYSICIAN WILL PROCEED WITH SECONDARY PROCEDURE. ADDITIONAL INFORMATION RECEIVED ON 11/14/2025: IT IS A TYPE 3 ENDOLEAK. NOT SURE IF 3A OR 3B AS THE GRAFT IS NOT SEPARATED TO SAY IT IS CONFIRMED 3A. HOWEVER, IT COULD BE LEAKING BETWEEN THE PIECES OR SOME LEAK DUE TO FABRIC INTEGRITY. NOT SURE YET. THIS PATIENT DID HAVE MAXIMUM OVERLAP WITH THE DEVICES." PATIENT OUTCOME: "PATIENT IS OK CAME IN FOR ROUTINE FOLLOW UP".
Patient problems: Clinical Endoleak
MAUDE report 23789859 ↗InjuryMay 2, 2025Device Endoleak; Device Endoleak
"UP UNTIL THE BALLOONING PORTION OF THIS PROCEDURE, THE CASE HAD GONE SMOOTHLY AND WITHOUT ISSUE. THE MAIN BODY LANDED ON OUR MARKS, AND THE ILIAC LIMB EXTENSIONS LANDED JUST PROXIMAL TO THE HYPOGASTRIC OSTIUMS. A MOLDING BALLOON WAS INTRODUCED AND THE PROXIMAL SEAL WAS BALLOONED WITHOUT ISSUE. WE THEN MOVED DOWN INTO THE LEFT ILIAC LIMB AND BALLOONED ALL ALONG THE LEG FOR SEAL, NO ISSUES WERE OBSERVED. THE BALLOON WAS THEN INTRODUCED TO THE RIGHT ILIAC LIMB EXTENSION AND THE BALLOON WAS PLACED IN THE GATE TO SEAL THE PROXIMAL END OF THE LIMB EXTENSION. AS THE TECH BALLOONED THE BIFURCATION, A MUSHROOM SHAPE WAS OBSERVED. WHEN ENOUGH BALLOONING WAS EXPRESSED BY THE REP, THE TECH CONTINUED TO PUSH AND THE MUSHROOM SHAPE THEN WAS SEEN TO CHANGE INTO A FULL BALLOON SHAPE WITH A "POPPING" OBSERVATION, MUCH LIKE WHEN STABILIZING A DISSECTION. THE REST OF THE LIMB WAS MOLDED TO THE ARTERY USING A MOLDING BALLOON, WITH NO ISSUE. UPON FINAL SHOT, AN ENDOLEAK WAS OBSERVED INSIDE THE GRAFT AT THE LEVEL OF THE BIFURCATION, WE RE-BALLOONED THE BIFURCATION AND LIMBS ONLY TO CONTINUE TO SHOW EVIDENCE OF AN ENDOLEAK FROM THE SITE. WE THEN USED VBX STENTS IN ATTEMPT TO RAISE THE BIFURCATION AND SE
Patient problems: Clinical Endoleak
MAUDE report 21950006 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P190015. One submission often covers many models, so check the product and lot details in each record.
- Z-1689-2023 · May 3, 2023 · Open, ClassifiedThe TREO ABDOMINAL STENT-GRAFT SYSTEM (TREO) consists of four types of implants, specifically a Main Bifurcated Stent-Graft, a Leg Extension Stent-Graft, a Proximal Cuff Stent-Graf
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page